Pediatrics News

Professional fulfillment can be achieved through a culture of wellness, efficiency of practice in the workplace and personal resilience, according to a speaker at the Ending Clinician Burnout Global Summit.

Young children at high genetic risk for type 1 diabetes may be more likely to progress to the disease based on their dietary intake, according to a presenter at the European Association for the Study of Diabetes annual meeting.

As kids return to school, the CDC has reminded the public that children with lice do not need to cut their school day short and be sent home early.

Acute-care visits for respiratory tract infections were nearly 20% lower than predicted among infants in New York after the state implemented paid family leave, according to a study published in JAMA Pediatrics.

Girls with diagnosed mental health conditions had lower HPV vaccination coverage than their peers without mental health conditions, according to a study published in The Lancet Public Health.

Hepatitis B e-antigen seroconversion in childhood and low hepatitis B surface antigen titers after seroconversion independently predicted functional cure in chronic HBV-infected patients followed from childhood through adulthood.

Low-value care encounters are more likely to occur in neighborhoods with a high Childhood Opportunity Index, but the overall volume of low-value care encounters is highest among areas with a low index, according to a study.

The White House moved to strengthen the Mental Health Parity and Addiction Equality Act to ensure individuals with private insurance have the same access to mental health services as they do for physical health services.

Presence of a fever and time since symptom onset were two factors that affected whether providers prescribed oseltamivir to infants with influenza, according to findings published in Journal of the Pediatric Infectious Diseases Society.

The FDA has granted rare pediatric disease designation to Descartes-08, an autologous mRNA cell therapy, for the treatment of juvenile dermatomyositis, Cartesian Therapeutics announced in a press release.